default author photo

Sundararaj Stanleyraj Jeremiah

Yokohama City University - Department of Microbiology

Japan

SCHOLARLY PAPERS

2

DOWNLOADS

92

TOTAL CITATIONS

1

Scholarly Papers (2)

1.

Identification of Serum Prognostic Biomarkers of Severe COVID-19 by Multi-Layered Quantitative Proteomic Approach

Number of pages: 67 Posted: 06 Nov 2020
Yokohama City University - Advanced Medical Research Center, Yokohama City University - Advanced Medical Research Center, Yokohama City University - Advanced Medical Research Center, Yokohama City University - School of Medicine Medical Course Biostatistics, Yokohama City University - School of Medicine Medical Course Biostatistics, Yokohama City University - Department of Microbiology, Yokohama City University - Department of Microbiology, Yokohama City University - Advanced Medical Research Center, Yokohama City University - Advanced Medical Research Center, Yokohama City University - Advanced Medical Research Center, Yokohama City University - School of Medicine Medical Course Emergency Medicine, Yokohama City University - School of Medicine Medical Course Emergency Medicine, Yokohama City University - School of Medicine Medical Course Emergency Medicine, Kanagawa Cardiovascular and Respiratory Center - Department of Respiratory Medicine, Yokohama City University - Department of Pulmonology, Yokohama City University - School of Medicine Medical Course Biostatistics, Yokohama City University - Department of Pulmonology, Yokohama City University - School of Medicine Medical Course Emergency Medicine, Kanagawa Cardiovascular and Respiratory Center - Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center - Department of Respiratory Medicine, Yokohama City University - Department of Immunology, Yokohama City University - School of Medicine Medical Course Biostatistics and Yokohama City University - Department of Microbiology
Downloads 50 (1,063,489)
Citation 1

Abstract:

Loading...

COVID-19, Proteomics, Biomarker, Prognosis, Diagnosis

2.

Highly Specific Monoclonal Antibodies Against SARS-CoV-2 Nucleocapsid Antigen for Accurate Diagnosis of COVID-19

Number of pages: 33 Posted: 29 Oct 2020
Yokohama City University - Department of Microbiology, Yokohama City University - Department of Microbiology, Yokohama City University - Department of Microbiology, Yokohama City University - Department of Pathology, Yokohama City University - Department of Microbiology, Kanto Chemical Co., Inc. - Life Science Laboratory, Yokohama City Institute of Public Health, Yokohama City Institute of Public Health, Yokohama City Institute of Public Health, Yokohama City University - Department of Microbiology, Yokohama Municipal Citizen's Hospital - Division of Pathology, Yokohama City University - Department of Pathology, Kanto Chemical Co., Inc. - Life Science Laboratory, Kanto Chemical Co., Inc. - Life Science Laboratory, Yokohama Municipal Citizen's Hospital - Division of Infectious Disease, Yokohama City University - Department of Physiology, Yokohama City University - Clinical Laboratory Department, National Institute of Infectious Diseases - Department of Pathology, Gunma Paz University - School of Medical Technology, Faculty of Health Sciences, National Institute of Infectious Diseases - Department of Pathology and Yokohama City University - Department of Microbiology
Downloads 42 (1,157,785)

Abstract:

Loading...

COVID-19, SARS-CoV-2, monoclonal antibody, nucleoprotein, point-of-care testing